【レポートの概要（一部）】
1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Segmentation
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitation
1.5 Market Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.4 Key Data From Secondary Sources
2.5 Key Data From Primary Sources
2.6 Key Industry Insights
2.7 Assumptions for the Study
3 Executive Summary (Page No. – 27)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights (Page No. – 31)
4.1 Global Vaccines Market
4.2 Vaccines Market, By Type
4.3 Geographic Analysis: Market, By End User
4.4 Geographic Analysis: Market, By Technology
4.5 Geographical Snapshot of the Market
4.6 Lifecycle Analysis, By Region, 2016
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Diseases
5.3.1.2 Rising Government and Non-Government Funding for Vaccine Development
5.3.1.3 Increasing Investments By Companies
5.3.1.4 Increasing Government Focus on Immunization Programs
5.3.2 Restraints
5.3.2.1 Huge Capital Investments
5.3.2.2 Stringent Regulations
5.3.3 Opportunities
5.3.3.1 High Growth Prospects in Emerging Markets
5.3.3.2 Therapeutic Vaccines
5.3.3.3 Adjuvant Vaccines
5.3.4 Challenges
5.3.4.1 Inadequate Access to Vaccines
5.3.4.2 Vaccine Pricing
5.3.5 Burning Issues
5.3.5.1 Vaccine Failure
5.4 Investment Analysis
5.5 Regulatory Landscape
5.5.1 North America
5.5.2 Europe
5.5.3 Asia
5.5.4 RoW
5.6 Patent Analysis
5.7 Key Pipeline Products
6 Vaccines Market, By Technology (Page No. – 57)
6.1 Introduction
6.2 Conjugate Vaccines
6.3 Inactivated and Subunit Vaccines
6.4 Live Attenuated Vaccines
6.5 Toxoid Vaccines
6.6 Recombinant Vaccines
7 Vaccines Market, By Type (Page No. – 66)
7.1 Introduction
7.2 Monovalent Vaccines
7.3 Multivalent Vaccines
8 Vaccines Market, By Disease Indication (Page No. – 71)
8.1 Introduction
8.2 Pneumococcal Disease
8.3 DTP
8.4 Influenza
8.5 Human Papilloma Virus
8.6 Meningococcal Disease
8.7 Polio
8.8 Rotavirus
8.9 Hepatitis
8.10 MMR
8.11 Varicella
8.12 Others
9 Vaccines Market, By End User (Page No. – 87)
9.1 Introduction
9.2 Pediatrics
9.3 Adults
10 Vaccines Market, By Region (Page No. – 92)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
11 Competitive Landscape (Page No. – 120)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Agreements, Collaborations, and Partnerships
11.3.2 Regulatory Approvals
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments
12 Company Profiles (Page No. – 127)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Pfizer, Inc.
12.3 Glaxosmithkline, PLC.
12.4 Merck & Co., Inc.
12.5 Sanofi Pasteur
12.6 CSL Limited
12.7 Emergent Biosolutions, Inc.
12.8 Johnson & Johnson
12.9 Medimmune, LLC. (A Subsidiary of Astrazeneca)
12.10 Astellas Pharma Inc.
12.11 Serum Institute of India
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 151)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
List of Tables (89 Tables)
Table 1 Incidence of Diseases, 2014-2015
Table 2 Nih Funding for Vaccine Research, 2012-2016 (USD Million)
Table 3 High Prevalence of Diseases to Boost the Vaccines Market
Table 4 Huge Capital Investments to Limit the Market Growth of Vaccines
Table 5 High Growth Potential in Emerging Countries to Boost the Market for Vaccines
Table 6 Immunization Coverage, By Disease, 2014
Table 7 Inadequate Access to Vaccines A Major Challenge in the Market
Table 8 Regulatory Authorities in Europe
Table 9 Regulatory Authorities in Asia
Table 10 Key Pipeline Vaccines
Table 11 Market Size, By Technology, 2014–2021 (USD Million)
Table 12 Conjugate Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 13 Examples of Inactivated and Subunit Vaccines
Table 14 Inactivated and Subunit Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 15 Live Attenuated Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 16 Toxoid Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 17 Recombinant Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 18 Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 19 Monovalent Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 20 Examples of Multivalent Vaccines
Table 21 Multivalent Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 22 Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 23 List of Pneumococcal Vaccines
Table 24 Market Size for Pneumococcal Disease, By Region, 2014–2021 (USD Million)
Table 25 List of DTP Vaccines
Table 26 Market Size for DTP, By Region, 2014–2021 (USD Million)
Table 27 List of Influenza Vaccines
Table 28 Market Size for Influenza, By Region, 2014–2021 (USD Million)
Table 29 List of Hpv Vaccines
Table 30 Market for Hpv, By Region, 2014–2021 (USD Million)
Table 31 List of Meningococcal Vaccines
Table 32 Market Size for Meningococcal Disease, By Region, 2014–2021 (USD Million)
Table 33 List of Polio Vaccines
Table 34 Polio Market Size, By Region, 2014–2021 (USD Million)
Table 35 List of Rotavirus Vaccines
Table 36 Market Size for Rotavirus, By Region, 2014–2021 (USD Million)
Table 37 List of Hepatitis Vaccines
Table 38 Market Size for Hepatitis, By Region, 2014–2021 (USD Million)
Table 39 List of MMR Vaccines
Table 40 Market Size for MMR, By Region, 2014–2021 (USD Million)
Table 41 List of Varicella Vaccines
Table 42 Market Size for Varicella, By Region, 2014–2021 (USD Million)
Table 43 List of Other Vaccines
Table 44 Market Size for Other Diseases, By Region, 2014–2021 (USD Million)
Table 45 Market Size, By End User, 2014–2021 (USD Million)
Table 46 Market Size for Pediatrics, By Region, 2014–2021 (USD Million)
Table 47 North America: Market Size for Pediatrics, By Country, 2014–2021 (USD Million)
Table 48 Market Size for Adults, By Region, 2014–2021 (USD Million)
Table 49 North America: Market Size for Adults, By Country, 2014–2021 (USD Million)
Table 50 Market Size, By Region, 2014–2021 (USD Million)
Table 51 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 52 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 53 North America: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 54 North America: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 55 North America: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 56 U.S.: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 57 U.S.: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 58 Canada: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 59 Canada: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 60 Europe: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 61 Europe: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 62 Europe: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 63 Europe: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 64 Europe: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 65 Germany: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 66 U.K.: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 67 France: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 68 Italy: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 69 Spain: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 70 RoE: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 71 Asia: Health Expenditure Per Capita, By Country, 2000 & 2014 (USD)
Table 72 Asia: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 73 Asia: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Asia: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 75 Asia: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 76 Asia: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 77 Japan: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 78 China: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 79 India: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 80 RoA: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 81 RoW: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 82 RoW: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 83 RoW: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 84 RoW: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 85 Agreements, Collaborations, and Partnerships, 2013-2016
Table 86 Regulatory Approvals, 2013-2016
Table 87 Acquisitions, 2013-2016
Table 88 Expansions, 2013-2016
Table 89 Other Developments, 2013-2016
List of Figures (55 Figures)
Figure 1 Vaccines Market Segmentation
Figure 2 Research Design
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Vaccines Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 8 Global Vaccines Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Vaccines Market, By Disease Indication, 2016
Figure 10 Global Vaccines Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Global Vaccines Market, By Region, 2016 (USD Million)
Figure 12 High Prevalence of Diseases and Rising Government & Non-Government Funding for Vaccine Development Primary Growth Drivers for the Global Vaccines Market
Figure 13 Monovalent Vaccines Segment to Witness High Growth During the Forecast Period
Figure 14 Pediatrics Segment to Dominate the Vaccines Market in 2021
Figure 15 Conjugate Vaccines Segment to Account for the Largest Market Share in 2016
Figure 16 U.S. to Dominate the Vaccines Market in 2016
Figure 17 Asia to Witness the Highest Growth Rate in the Vaccines Market During the Forecast Period
Figure 18 Vaccine Market Segmentation
Figure 19 Vaccine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Investors Play an Important Role in the Vaccines Market
Figure 21 Vaccine Funding, By Investor, 2014
Figure 22 Gavi Vaccine Funding, By Type of Investor, 2014
Figure 23 HIV Preventive Vaccines R&D Funding, By Investor, 2014
Figure 24 Regulatory Approval Process for Vaccines
Figure 25 North America Accounted for the Largest Number of Patent Filings in 2012
Figure 26 The U.S. Accounted for Largest Number of Patent Filings Across the Globe (2012)
Figure 27 Conjugate Vaccines Segment to Dominate the Vaccines Market During the Forecast Period
Figure 28 Asian Market for Live Attenuated Vaccines to Register the Highest CAGR During the Forecast Period
Figure 29 North America is Expected to Dominate the Recombinant Vaccines Market During the Forecast Period
Figure 30 Monovalent Vaccines to Dominate the Global Vaccines Market From 2016 to 2021
Figure 31 North America is Expected to Dominate the Multivalent Vaccines Market During the Forecast Period
Figure 32 Pneumococcal Disease Segment Expected to Dominate the Market During the Forecast Period
Figure 33 Asia is Expected to Grow at the Highest CAGR in the Influenza Disease Segment During the Forecast Period
Figure 34 North America to Dominate the Meningococcal Disease Market During the Forecast Period
Figure 35 Asian Market for Hepatitis Vaccines to Grow at the Highest CAGR During the Forecast Period
Figure 36 The Pediatrics End-User Segment Dominates the Global Vaccines Market in 2016
Figure 37 Asia to Witness the Highest Growth Rate in the Vaccines Market for Adults During the Forecast Period
Figure 38 Geographic Snapshot (2016): Emerging Markets to Offer Growth Opportunities
Figure 39 Geographic Benchmarking for Vaccines Technology Market
Figure 40 North America: Vaccines Market Snapshot, 2016
Figure 41 Europe: Vaccines Market Snapshot, 2016
Figure 42 Asia: Vaccines Market Snapshot, 2016
Figure 43 Organic and Inorganic Growth Strategies Adopted By Key Market Players From 2013 to 2016
Figure 44 Global Vaccines Market Share, By Key Player, 2015
Figure 45 Battle for Market Share: Agreements, Collaborations, and Partnerships Were the Preferred Strategies By Market Players
Figure 46 Product Benchmarking for Top 4 Market Players
Figure 47 Pfizer, Inc.: Company Snapshot
Figure 48 Glaxosmithkline, PLC.: Company Snapshot
Figure 49 Merck & Co., Inc.: Company Snapshot
Figure 50 Sanofi Pasteur: Company Snapshot
Figure 51 CSL Limited: Company Snapshot
Figure 52 Emergent Biosolutions: Company Snapshot
Figure 53 Johnson & Johnson: Company Snapshot
Figure 54 Astrazeneca : Company Snapshot
Figure 55 Astellas Pharma Inc.: Company Snapshot
【レポート販売概要】
■ タイトル：ワクチンの世界市場：弱毒生ワクチン、トキソイドワクチン、結合型ワクチン、不活化＆サブユニットワクチン、組換え型ワクチン■ 英文：Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021
■ 発行日：2016年8月9日
■ 調査会社：MarketsandMarkets
■ 商品コード：BT-3113
■ 調査対象地域：グローバル
- 2014年戦略提言：スペインのHIV/AIDS診断・検査市場Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in Spain. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals …
- 冷凍ピザの世界市場予測・分析2019-2023Global Frozen Pizza Market: About this market Technavio’s frozen pizza market analysis considers sales from regular frozen pizza, premium frozen pizza, and gourmet frozen pizza. Our analysis also considers the sales of frozen pizza in APAC, Europe, North America, South America, and MEA. In 2018, the regular frozen pizza segment had a significant market share, and this trend is expected to continue …
- 手術用顕微鏡の世界市場予測（～2021年）The global surgical/operating microscopes market is expected to reach USD 915.6 million in 2021 from USD 508.1 million in 2016, at a CAGR of 12.5% from 2016 to 2021. The increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions are …
- 農業機械向け融資の世界市場2019-2023About this market Agricultural equipment finance provides quick and easy access to credit unlike traditional financial institutions, which may take more than a day to complete the paperwork for the loan application. Many banks also have policies that encourage them to provide loans to farmers due to government support. In addition, alternative finance caters to such businesses by providing quick a …
- 非破壊検査装置の世界市場：超音波探傷試験、放射線透過試験、目視試験About NDT Equipment NDT equipment is used to evaluate and examine the properties of an object, material, or system without damaging it. The equipment includes three major components: ultrasonic, radiography, and visual test equipment. The major end-users of NDT equipment are industries in the Power Generation, Oil and Gas, Aerospace, and Automotive sectors. TechNavio's analysts forecast the Global …
- 世界のADC（抗体－薬物複合体）市場展望（～2018）The ADC technology is not new. It dates back to the 90s. However, several issues such as specificity of the payload (drug), and poor conjugation of drug and antibody proved a setback. But, the past few years have witnessed ADCs make a glorious comeback. This can be attributed to the significant advancements that have been made in the field of linker technology as well as payload efficacy and speci …
- BRIC（ブラジル/ロシア/インド/中国）の原子力発電市場About Nuclear Power Nuclear power in BRIC countries is expected to experience moderate growth during the period 2014-2018. The cumulative installed capacity for nuclear power in BRIC countries was 47.8 GW in 2013, Russia being the leading country among BRIC nations, with cumulative installed capacity of 25.2 GW. China is expected to have the maximum capacity additions in the forecast period and wi …
- バスマティ米の世界市場：種別（白米、玄米、その他）、販売チャネル別（従来式販売、最新式販売、小売、HORECA）、地域別予測Global Basmati Rice Market to reach USD 23.9 billion by 2025. Global Basmati Rice Market valued approximately USD 9.2 billion in 2016 is anticipated to grow with a healthy growth rate of more than 11.2% over the forecast period 2017-2025. the global basmati rice market is undergoing a phase of significant improvement as consumers appreciate the quality and taste of basmati. With rice being one of …
- Reliance Industries Limited：石油・ガスバリューチェーン分析レポート2013Reliance Industries Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Reliance Industries Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Reliance Industries Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value c …
- 象皮症(リンパ系フィラリア症)(Elephantiasis (Lymphatic Filariasis))の治療薬パイプライン動向（2015年上半期版）Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015’, provides an overview of the Elephantiasis (Lymphatic Filariasis)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Elephantiasis (Lymphatic Filariasis), complete with comparative a …
- モバイル暗号化の世界市場予測（～2022年）：ディスク暗号化、ファイル/フォルダ暗号化、通信暗号化、クラウド暗号化“Need for stringent compliance and increasing concern for data security are driving the mobile encryption market.”The mobile encryption market size is expected to grow from USD 761.4 million in 2017 to USD 2,917.9 million by 2022, at a Compound Annual Growth Rate (CAGR) of 30.8%. The market is driven by factors such as increased concerns for data security and privacy issues, the proliferation of s …
- 世界のガス絶縁変電所市場2015The Global Gas Insulated Substation Industry Report 2015 is a professional and in-depth study on the current state of the Gas Insulated Substation industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Gas Insulated Substation market analysis is provided for the international markets including development …
- Continental Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 世界のスープ市場のM&A動向（2014年7月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global soups market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global soups market throughout the month. Additionally, the report provides an overview of all the partnering, all …
- 2014年戦略提言：フランスの腸疾患診断検査市場About This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Priva …
